Jiuding Capital launches $73 mln pharma PE fund
Shanghai. November 30. INTERFAX-CHINA - Kunwu Jiuding Capital Co. Ltd. has launched a RMB 500 million ($73.21 million) pharmaceutical private equity investment fund, it announced on Nov. 27.
According to the announcement, this is Beijing-based Jiuding Capital's first PE fund directed towards China's pharmaceutical industry. Jiuding Capital aims to invest in drug manufacturers, health care service providers, drug distributors and pharmaceutical research and development (R & D) companies over the next two years.
"Apart from investing in the pharmaceutical targets, we will also provide consultancy services to those companies, including initial public offering (IPO), enterprise management, merger and acquisitions and human resources," Zhao Zhongyi, Jiuding Pharma's executive president, told Interfax on Nov. 30.